跳至主要内容
临床试验/NCT01963624
NCT01963624已完成不适用

Multicenter Prospective Study to Evaluate the Value of Combined Elastography and Color Doppler Ultrasonography for Breast Screening With Ultrasound

Seoul National University Hospital10 个研究点 分布在 1 个国家目标入组 1,241 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,241
试验地点
10
主要终点
Positive predictive value of breast screening with US

研究概览

简要总结

The investigators hypothesis is that the combined use of elastography and color doppler ultrasonography can increase positive-predictive value of breast screening with ultrasound.

详细描述

  • Asymptomatic women who undergo breast screening with ultrasound and has breast masses of Breast Imaging Reporting and Data System (BI-RADS) category 3 or higher will be examined with conventional B-mode US as well as combined elasto-doppler US by breast radiologists.
  • The likelihood of malignancy and BI-RADS category of the breast masses are assessed for each dataset of B-mode US alone and B-mode US with elasto-doppler US, respectively.
  • Reference standard: Biopsy or 1 year of follow-up examination.
  • The positive-predictive value, sensitivity, specificity, and diagnostic accuracy (assessed by the area under the receiver operating characteristic curve) are evaluated and compared between B-mode US alone and B-mode US with elasto-doppler US.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 30 years or older screened with breast ultrasound without specific symptoms
  • Women who underwent mammography within 3 months which showed no abnormality except for dense breast
  • Women who had at least one breast mass of BI-RADS category 3 or higher.

排除标准

  • Women with breast implants
  • Women who are unwilling or unable to provide informed consent
  • Lesions larger than 3 cm
  • Lesions that are previously noted and followed-up in the same hospital

结局指标

主要结局

Positive predictive value of breast screening with US

时间窗: 1 year after enrollment

Stability for 1 year of follow-up is needed for the confirmation of benign lesions if they do not undergo biopsy.

次要结局

  • Sensitivity(1 year after enrollment)
  • Specificity(1 year after enrollment)
  • Diagnostic accuracy(1 year after enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Woo Kyung Moon

Professor

Seoul National University Hospital

研究点 (10)

Loading locations...

相似试验